BTI has created a unprecedented biological sensor that will disrupt medical, food safety, and homeland security markets.

Bridger Technologies, Inc. (BTI) is in the final stages of its corporate mission by engaging entities offering to acquire its equity and assets including all remaining licenses, rights and royalties. Supported through private and government funds, BTI has successfully developed a novel diagnostic biological detection instrument. The US and international patent protected device and concepts will disrupt the food, medical, and military (billion dollar?) biosensor markets. Detection of disease-...

Bridger Technologies, Inc. (BTI) is in the final stages of its corporate mission by engaging entities offering to acquire its equity and assets including all remaining licenses, rights and royalties. Supported through private and government funds, BTI has successfully developed a novel diagnostic biological detection instrument. The US and international patent protected device and concepts will disrupt the food, medical, and military (billion dollar?) biosensor markets. Detection of disease-causing agents with this technology is cost effective, user-friendly, faster (<1 min), more sensitive and resistant to contaminants than any competitive technologies. BTI continues to refine the technology and expand the Target range specifically for the military and homeland security markets.